Citizens Maintains Market Outperform on Artivion, Lowers Price Target to $48
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and lowers the price target from $53 to $48.
Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and lowers the price target from $53 to $48.